nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP4A11—Rifampicin—leprosy	0.251	0.31	CbGbCtD
Tretinoin—CYP2C18—Dapsone—leprosy	0.0911	0.112	CbGbCtD
Tretinoin—CYP2A6—Rifampicin—leprosy	0.0536	0.0661	CbGbCtD
Tretinoin—CYP1A1—Thalidomide—leprosy	0.0473	0.0583	CbGbCtD
Tretinoin—CYP3A7—Rifampicin—leprosy	0.0367	0.0452	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0367	0.0452	CbGbCtD
Tretinoin—CYP2B6—Rifampicin—leprosy	0.0349	0.043	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0303	0.0373	CbGbCtD
Tretinoin—CYP3A7—Dapsone—leprosy	0.0303	0.0373	CbGbCtD
Tretinoin—CYP3A5—Thalidomide—leprosy	0.0284	0.035	CbGbCtD
Tretinoin—CYP3A5—Rifampicin—leprosy	0.0275	0.0339	CbGbCtD
Tretinoin—CYP2C8—Rifampicin—leprosy	0.0264	0.0326	CbGbCtD
Tretinoin—CYP3A5—Dapsone—leprosy	0.0227	0.028	CbGbCtD
Tretinoin—CYP2C8—Dapsone—leprosy	0.0218	0.0269	CbGbCtD
Tretinoin—CYP2C9—Thalidomide—leprosy	0.019	0.0235	CbGbCtD
Tretinoin—CYP2C9—Rifampicin—leprosy	0.0184	0.0227	CbGbCtD
Tretinoin—CYP2C9—Dapsone—leprosy	0.0152	0.0188	CbGbCtD
Tretinoin—CYP3A4—Rifampicin—leprosy	0.0107	0.0132	CbGbCtD
Tretinoin—CYP3A4—Dapsone—leprosy	0.00885	0.0109	CbGbCtD
Tretinoin—Application site erythema—Dapsone—leprosy	0.00528	0.0387	CcSEcCtD
Tretinoin—Application site pruritus—Dapsone—leprosy	0.0051	0.0374	CcSEcCtD
Tretinoin—CRABP2—skin epidermis—leprosy	0.00504	0.0965	CbGeAlD
Tretinoin—Localized exfoliation—Dapsone—leprosy	0.00462	0.0339	CcSEcCtD
Tretinoin—Acquired immunodeficiency syndrome—Thalidomide—leprosy	0.00317	0.0233	CcSEcCtD
Tretinoin—Teratogenicity—Thalidomide—leprosy	0.00304	0.0223	CcSEcCtD
Tretinoin—Application site pain—Dapsone—leprosy	0.00283	0.0207	CcSEcCtD
Tretinoin—Application site reaction—Dapsone—leprosy	0.00265	0.0194	CcSEcCtD
Tretinoin—RARRES1—skin of body—leprosy	0.00233	0.0447	CbGeAlD
Tretinoin—Suicide attempt—Dapsone—leprosy	0.00219	0.0161	CcSEcCtD
Tretinoin—CRABP1—eye—leprosy	0.00199	0.038	CbGeAlD
Tretinoin—Autoimmune disorder—Thalidomide—leprosy	0.00191	0.014	CcSEcCtD
Tretinoin—CRABP2—eye—leprosy	0.0018	0.0344	CbGeAlD
Tretinoin—RARRES1—tendon—leprosy	0.00178	0.034	CbGeAlD
Tretinoin—CRABP1—skin of body—leprosy	0.00173	0.0331	CbGeAlD
Tretinoin—RXRG—eye—leprosy	0.00157	0.03	CbGeAlD
Tretinoin—CRABP2—skin of body—leprosy	0.00156	0.0299	CbGeAlD
Tretinoin—Dementia—Thalidomide—leprosy	0.00155	0.0114	CcSEcCtD
Tretinoin—Rales—Thalidomide—leprosy	0.00155	0.0114	CcSEcCtD
Tretinoin—ALDH1A1—eye—leprosy	0.0015	0.0286	CbGeAlD
Tretinoin—Pericarditis—Thalidomide—leprosy	0.00147	0.0108	CcSEcCtD
Tretinoin—Erythema nodosum—Thalidomide—leprosy	0.00147	0.0108	CcSEcCtD
Tretinoin—RARRES1—testis—leprosy	0.00147	0.0282	CbGeAlD
Tretinoin—Proteinuria—Dapsone—leprosy	0.00142	0.0104	CcSEcCtD
Tretinoin—Hyporeflexia—Thalidomide—leprosy	0.0014	0.0103	CcSEcCtD
Tretinoin—Ascites—Thalidomide—leprosy	0.0014	0.0103	CcSEcCtD
Tretinoin—Protein urine present—Dapsone—leprosy	0.0014	0.0102	CcSEcCtD
Tretinoin—CRABP1—tendon—leprosy	0.00132	0.0252	CbGeAlD
Tretinoin—RARG—eye—leprosy	0.00131	0.0251	CbGeAlD
Tretinoin—ALDH1A1—skin of body—leprosy	0.0013	0.0249	CbGeAlD
Tretinoin—White blood cell count decreased—Thalidomide—leprosy	0.00128	0.00938	CcSEcCtD
Tretinoin—NR0B1—testis—leprosy	0.00127	0.0242	CbGeAlD
Tretinoin—CYP1A1—skin epidermis—leprosy	0.00127	0.0242	CbGeAlD
Tretinoin—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00124	0.00912	CcSEcCtD
Tretinoin—CRABP2—tendon—leprosy	0.00119	0.0228	CbGeAlD
Tretinoin—Skin exfoliation—Dapsone—leprosy	0.00119	0.00871	CcSEcCtD
Tretinoin—RARG—skin of body—leprosy	0.00114	0.0218	CbGeAlD
Tretinoin—Vesiculobullous rash—Thalidomide—leprosy	0.00114	0.00833	CcSEcCtD
Tretinoin—ALDH1A2—testis—leprosy	0.00113	0.0216	CbGeAlD
Tretinoin—Foetor hepaticus—Thalidomide—leprosy	0.00112	0.00823	CcSEcCtD
Tretinoin—Suicide attempt—Thalidomide—leprosy	0.00112	0.00823	CcSEcCtD
Tretinoin—ALDH1A2—nervous system—leprosy	0.00111	0.0212	CbGeAlD
Tretinoin—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0011	0.00803	CcSEcCtD
Tretinoin—CRABP1—testis—leprosy	0.00109	0.0208	CbGeAlD
Tretinoin—CRABP1—nervous system—leprosy	0.00107	0.0205	CbGeAlD
Tretinoin—RARB—tendon—leprosy	0.00106	0.0204	CbGeAlD
Tretinoin—Febrile neutropenia—Thalidomide—leprosy	0.00106	0.00776	CcSEcCtD
Tretinoin—RXRG—tendon—leprosy	0.00104	0.0199	CbGeAlD
Tretinoin—Serum creatinine increased—Thalidomide—leprosy	0.00104	0.00759	CcSEcCtD
Tretinoin—Embolism—Thalidomide—leprosy	0.000992	0.00727	CcSEcCtD
Tretinoin—ALDH1A1—tendon—leprosy	0.000991	0.019	CbGeAlD
Tretinoin—CRABP2—testis—leprosy	0.000985	0.0188	CbGeAlD
Tretinoin—Nail disorder—Thalidomide—leprosy	0.000982	0.0072	CcSEcCtD
Tretinoin—RXRB—tendon—leprosy	0.000978	0.0187	CbGeAlD
Tretinoin—CRABP2—nervous system—leprosy	0.000967	0.0185	CbGeAlD
Tretinoin—RXRA—nervous system—leprosy	0.000963	0.0184	CbGeAlD
Tretinoin—Liver disorder—Thalidomide—leprosy	0.000934	0.00685	CcSEcCtD
Tretinoin—Menstrual disorder—Thalidomide—leprosy	0.000934	0.00685	CcSEcCtD
Tretinoin—Seborrhoeic dermatitis—Thalidomide—leprosy	0.000934	0.00685	CcSEcCtD
Tretinoin—Hypercalcaemia—Thalidomide—leprosy	0.000917	0.00672	CcSEcCtD
Tretinoin—Lung disorder—Thalidomide—leprosy	0.0009	0.0066	CcSEcCtD
Tretinoin—Thrombosis—Thalidomide—leprosy	0.0009	0.0066	CcSEcCtD
Tretinoin—Cyanosis—Thalidomide—leprosy	0.0009	0.0066	CcSEcCtD
Tretinoin—Hyperlipidaemia—Thalidomide—leprosy	0.000884	0.00648	CcSEcCtD
Tretinoin—Psychotic disorder—Dapsone—leprosy	0.000882	0.00647	CcSEcCtD
Tretinoin—RARG—tendon—leprosy	0.000868	0.0166	CbGeAlD
Tretinoin—RXRG—testis—leprosy	0.000861	0.0165	CbGeAlD
Tretinoin—RXRG—nervous system—leprosy	0.000845	0.0162	CbGeAlD
Tretinoin—Pleural effusion—Thalidomide—leprosy	0.000832	0.0061	CcSEcCtD
Tretinoin—ALDH1A1—testis—leprosy	0.000821	0.0157	CbGeAlD
Tretinoin—Skin ulcer—Thalidomide—leprosy	0.000818	0.006	CcSEcCtD
Tretinoin—RARA—tendon—leprosy	0.000816	0.0156	CbGeAlD
Tretinoin—Hyperaesthesia—Thalidomide—leprosy	0.000811	0.00595	CcSEcCtD
Tretinoin—RXRB—testis—leprosy	0.00081	0.0155	CbGeAlD
Tretinoin—Nasopharyngitis—Dapsone—leprosy	0.000808	0.00592	CcSEcCtD
Tretinoin—ALDH1A1—nervous system—leprosy	0.000806	0.0154	CbGeAlD
Tretinoin—Rash pustular—Thalidomide—leprosy	0.000799	0.00585	CcSEcCtD
Tretinoin—RXRB—nervous system—leprosy	0.000795	0.0152	CbGeAlD
Tretinoin—Tingling sensation—Thalidomide—leprosy	0.000792	0.00581	CcSEcCtD
Tretinoin—Numbness—Thalidomide—leprosy	0.000768	0.00563	CcSEcCtD
Tretinoin—Pancreatitis—Dapsone—leprosy	0.000765	0.00561	CcSEcCtD
Tretinoin—Acne—Thalidomide—leprosy	0.000757	0.00555	CcSEcCtD
Tretinoin—Sensory loss—Thalidomide—leprosy	0.000735	0.00539	CcSEcCtD
Tretinoin—Proteinuria—Thalidomide—leprosy	0.000725	0.00531	CcSEcCtD
Tretinoin—RARG—testis—leprosy	0.000719	0.0138	CbGeAlD
Tretinoin—Protein urine present—Thalidomide—leprosy	0.000715	0.00524	CcSEcCtD
Tretinoin—Photosensitivity reaction—Dapsone—leprosy	0.000713	0.00522	CcSEcCtD
Tretinoin—Musculoskeletal stiffness—Thalidomide—leprosy	0.00071	0.0052	CcSEcCtD
Tretinoin—RARG—nervous system—leprosy	0.000705	0.0135	CbGeAlD
Tretinoin—Skin discolouration—Thalidomide—leprosy	0.000705	0.00517	CcSEcCtD
Tretinoin—Cellulitis—Thalidomide—leprosy	0.0007	0.00513	CcSEcCtD
Tretinoin—Herpes simplex—Thalidomide—leprosy	0.000691	0.00507	CcSEcCtD
Tretinoin—Hyperuricaemia—Thalidomide—leprosy	0.000687	0.00503	CcSEcCtD
Tretinoin—Drug interaction—Thalidomide—leprosy	0.000687	0.00503	CcSEcCtD
Tretinoin—Neuropathy peripheral—Dapsone—leprosy	0.000682	0.005	CcSEcCtD
Tretinoin—Leukocytosis—Thalidomide—leprosy	0.000678	0.00497	CcSEcCtD
Tretinoin—RARA—testis—leprosy	0.000676	0.0129	CbGeAlD
Tretinoin—Hypercholesterolaemia—Thalidomide—leprosy	0.000673	0.00494	CcSEcCtD
Tretinoin—Hearing impaired—Thalidomide—leprosy	0.000669	0.0049	CcSEcCtD
Tretinoin—Bone pain—Thalidomide—leprosy	0.000665	0.00487	CcSEcCtD
Tretinoin—RARA—nervous system—leprosy	0.000663	0.0127	CbGeAlD
Tretinoin—Sinusitis—Dapsone—leprosy	0.000653	0.00479	CcSEcCtD
Tretinoin—Gait disturbance—Thalidomide—leprosy	0.000653	0.00478	CcSEcCtD
Tretinoin—Blood uric acid increased—Thalidomide—leprosy	0.000649	0.00475	CcSEcCtD
Tretinoin—Neck pain—Thalidomide—leprosy	0.000645	0.00473	CcSEcCtD
Tretinoin—Hepatocellular injury—Thalidomide—leprosy	0.000637	0.00467	CcSEcCtD
Tretinoin—Phosphatase alkaline increased—Thalidomide—leprosy	0.000637	0.00467	CcSEcCtD
Tretinoin—Pharyngitis—Dapsone—leprosy	0.00062	0.00455	CcSEcCtD
Tretinoin—Depressed level of consciousness—Thalidomide—leprosy	0.000615	0.00451	CcSEcCtD
Tretinoin—Colitis—Thalidomide—leprosy	0.000612	0.00448	CcSEcCtD
Tretinoin—Candida infection—Thalidomide—leprosy	0.000608	0.00446	CcSEcCtD
Tretinoin—Skin exfoliation—Thalidomide—leprosy	0.000608	0.00446	CcSEcCtD
Tretinoin—Dry eye—Thalidomide—leprosy	0.000588	0.00431	CcSEcCtD
Tretinoin—Tinnitus—Dapsone—leprosy	0.000583	0.00427	CcSEcCtD
Tretinoin—Oesophagitis—Thalidomide—leprosy	0.000582	0.00427	CcSEcCtD
Tretinoin—Rash maculo-papular—Thalidomide—leprosy	0.000579	0.00424	CcSEcCtD
Tretinoin—Lightheadedness—Thalidomide—leprosy	0.00057	0.00418	CcSEcCtD
Tretinoin—Pulmonary oedema—Thalidomide—leprosy	0.000567	0.00416	CcSEcCtD
Tretinoin—Sepsis—Thalidomide—leprosy	0.000553	0.00405	CcSEcCtD
Tretinoin—Euphoric mood—Thalidomide—leprosy	0.000547	0.00401	CcSEcCtD
Tretinoin—Erythema—Dapsone—leprosy	0.000544	0.00399	CcSEcCtD
Tretinoin—Lymphadenopathy—Thalidomide—leprosy	0.000542	0.00397	CcSEcCtD
Tretinoin—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000532	0.0039	CcSEcCtD
Tretinoin—Diabetes mellitus—Thalidomide—leprosy	0.000532	0.0039	CcSEcCtD
Tretinoin—Photosensitivity—Thalidomide—leprosy	0.000527	0.00386	CcSEcCtD
Tretinoin—Deafness—Thalidomide—leprosy	0.000517	0.00379	CcSEcCtD
Tretinoin—Eczema—Thalidomide—leprosy	0.000514	0.00377	CcSEcCtD
Tretinoin—Vision blurred—Dapsone—leprosy	0.000513	0.00376	CcSEcCtD
Tretinoin—Cardiac failure congestive—Thalidomide—leprosy	0.00051	0.00374	CcSEcCtD
Tretinoin—Renal failure acute—Thalidomide—leprosy	0.000501	0.00367	CcSEcCtD
Tretinoin—Dermatitis exfoliative—Thalidomide—leprosy	0.00049	0.00359	CcSEcCtD
Tretinoin—Visual disturbance—Thalidomide—leprosy	0.000488	0.00358	CcSEcCtD
Tretinoin—Dermatitis bullous—Thalidomide—leprosy	0.000484	0.00355	CcSEcCtD
Tretinoin—Arthritis—Thalidomide—leprosy	0.000476	0.00349	CcSEcCtD
Tretinoin—Cough—Dapsone—leprosy	0.000475	0.00348	CcSEcCtD
Tretinoin—Cardiac failure—Thalidomide—leprosy	0.000474	0.00347	CcSEcCtD
Tretinoin—Cerebrovascular accident—Thalidomide—leprosy	0.000472	0.00346	CcSEcCtD
Tretinoin—Lethargy—Thalidomide—leprosy	0.000472	0.00346	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000462	0.00339	CcSEcCtD
Tretinoin—Osteoarthritis—Thalidomide—leprosy	0.000462	0.00339	CcSEcCtD
Tretinoin—Pain in extremity—Thalidomide—leprosy	0.000462	0.00339	CcSEcCtD
Tretinoin—Affect lability—Thalidomide—leprosy	0.000455	0.00334	CcSEcCtD
Tretinoin—Psychotic disorder—Thalidomide—leprosy	0.000452	0.00331	CcSEcCtD
Tretinoin—Face oedema—Thalidomide—leprosy	0.000446	0.00327	CcSEcCtD
Tretinoin—Cardiac arrest—Thalidomide—leprosy	0.00044	0.00322	CcSEcCtD
Tretinoin—Mood swings—Thalidomide—leprosy	0.000438	0.00321	CcSEcCtD
Tretinoin—Tachycardia—Dapsone—leprosy	0.000433	0.00318	CcSEcCtD
Tretinoin—Blood creatinine increased—Thalidomide—leprosy	0.000433	0.00317	CcSEcCtD
Tretinoin—Dehydration—Thalidomide—leprosy	0.00043	0.00315	CcSEcCtD
Tretinoin—Dry skin—Thalidomide—leprosy	0.000424	0.00311	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000416	0.00305	CcSEcCtD
Tretinoin—Abdominal distension—Thalidomide—leprosy	0.000402	0.00295	CcSEcCtD
Tretinoin—Insomnia—Dapsone—leprosy	0.000401	0.00294	CcSEcCtD
Tretinoin—Dysphagia—Thalidomide—leprosy	0.0004	0.00293	CcSEcCtD
Tretinoin—Bronchospasm—Thalidomide—leprosy	0.000393	0.00288	CcSEcCtD
Tretinoin—CYP1A1—skin of body—leprosy	0.000392	0.0075	CbGeAlD
Tretinoin—Pancreatitis—Thalidomide—leprosy	0.000392	0.00287	CcSEcCtD
Tretinoin—CYP2B6—skin of body—leprosy	0.000381	0.00729	CbGeAlD
Tretinoin—Neutropenia—Thalidomide—leprosy	0.000374	0.00274	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Thalidomide—leprosy	0.000371	0.00272	CcSEcCtD
Tretinoin—Pollakiuria—Thalidomide—leprosy	0.000369	0.00271	CcSEcCtD
Tretinoin—Photosensitivity reaction—Thalidomide—leprosy	0.000365	0.00267	CcSEcCtD
Tretinoin—Weight increased—Thalidomide—leprosy	0.000364	0.00267	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dapsone—leprosy	0.000363	0.00266	CcSEcCtD
Tretinoin—Weight decreased—Thalidomide—leprosy	0.000362	0.00265	CcSEcCtD
Tretinoin—Pneumonia—Thalidomide—leprosy	0.000358	0.00263	CcSEcCtD
Tretinoin—Infestation—Thalidomide—leprosy	0.000356	0.00261	CcSEcCtD
Tretinoin—Infestation NOS—Thalidomide—leprosy	0.000356	0.00261	CcSEcCtD
Tretinoin—Drowsiness—Thalidomide—leprosy	0.000356	0.00261	CcSEcCtD
Tretinoin—Depression—Thalidomide—leprosy	0.000355	0.0026	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000353	0.00259	CcSEcCtD
Tretinoin—Acute coronary syndrome—Thalidomide—leprosy	0.000351	0.00257	CcSEcCtD
Tretinoin—Abdominal pain—Dapsone—leprosy	0.000351	0.00257	CcSEcCtD
Tretinoin—Body temperature increased—Dapsone—leprosy	0.000351	0.00257	CcSEcCtD
Tretinoin—Renal failure—Thalidomide—leprosy	0.00035	0.00257	CcSEcCtD
Tretinoin—Myocardial infarction—Thalidomide—leprosy	0.000349	0.00256	CcSEcCtD
Tretinoin—Neuropathy peripheral—Thalidomide—leprosy	0.000349	0.00256	CcSEcCtD
Tretinoin—Stomatitis—Thalidomide—leprosy	0.000347	0.00255	CcSEcCtD
Tretinoin—Conjunctivitis—Thalidomide—leprosy	0.000346	0.00254	CcSEcCtD
Tretinoin—Sweating—Thalidomide—leprosy	0.000342	0.0025	CcSEcCtD
Tretinoin—Haematuria—Thalidomide—leprosy	0.00034	0.00249	CcSEcCtD
Tretinoin—Epistaxis—Thalidomide—leprosy	0.000336	0.00246	CcSEcCtD
Tretinoin—Sinusitis—Thalidomide—leprosy	0.000334	0.00245	CcSEcCtD
Tretinoin—Agranulocytosis—Thalidomide—leprosy	0.000332	0.00244	CcSEcCtD
Tretinoin—Hepatitis—Thalidomide—leprosy	0.00032	0.00234	CcSEcCtD
Tretinoin—Hypoaesthesia—Thalidomide—leprosy	0.000318	0.00233	CcSEcCtD
Tretinoin—Pharyngitis—Thalidomide—leprosy	0.000317	0.00233	CcSEcCtD
Tretinoin—Urinary tract disorder—Thalidomide—leprosy	0.000316	0.00232	CcSEcCtD
Tretinoin—Oedema peripheral—Thalidomide—leprosy	0.000315	0.00231	CcSEcCtD
Tretinoin—Urethral disorder—Thalidomide—leprosy	0.000314	0.0023	CcSEcCtD
Tretinoin—Visual impairment—Thalidomide—leprosy	0.000308	0.00226	CcSEcCtD
Tretinoin—Erythema multiforme—Thalidomide—leprosy	0.000302	0.00222	CcSEcCtD
Tretinoin—Eye disorder—Thalidomide—leprosy	0.000299	0.00219	CcSEcCtD
Tretinoin—Tinnitus—Thalidomide—leprosy	0.000298	0.00219	CcSEcCtD
Tretinoin—Angiopathy—Thalidomide—leprosy	0.00029	0.00213	CcSEcCtD
Tretinoin—Chills—Thalidomide—leprosy	0.000287	0.0021	CcSEcCtD
Tretinoin—Arrhythmia—Thalidomide—leprosy	0.000286	0.00209	CcSEcCtD
Tretinoin—Alopecia—Thalidomide—leprosy	0.000283	0.00207	CcSEcCtD
Tretinoin—Vomiting—Dapsone—leprosy	0.000282	0.00207	CcSEcCtD
Tretinoin—Mental disorder—Thalidomide—leprosy	0.00028	0.00205	CcSEcCtD
Tretinoin—Malnutrition—Thalidomide—leprosy	0.000278	0.00204	CcSEcCtD
Tretinoin—Headache—Dapsone—leprosy	0.000278	0.00204	CcSEcCtD
Tretinoin—Flatulence—Thalidomide—leprosy	0.000274	0.00201	CcSEcCtD
Tretinoin—Tension—Thalidomide—leprosy	0.000273	0.002	CcSEcCtD
Tretinoin—Nervousness—Thalidomide—leprosy	0.00027	0.00198	CcSEcCtD
Tretinoin—Back pain—Thalidomide—leprosy	0.000269	0.00197	CcSEcCtD
Tretinoin—CYP2C8—testis—leprosy	0.000268	0.00512	CbGeAlD
Tretinoin—Nausea—Dapsone—leprosy	0.000264	0.00193	CcSEcCtD
Tretinoin—Vision blurred—Thalidomide—leprosy	0.000262	0.00192	CcSEcCtD
Tretinoin—Tremor—Thalidomide—leprosy	0.000261	0.00191	CcSEcCtD
Tretinoin—Ill-defined disorder—Thalidomide—leprosy	0.000258	0.00189	CcSEcCtD
Tretinoin—Anaemia—Thalidomide—leprosy	0.000257	0.00189	CcSEcCtD
Tretinoin—Agitation—Thalidomide—leprosy	0.000256	0.00188	CcSEcCtD
Tretinoin—Malaise—Thalidomide—leprosy	0.000251	0.00184	CcSEcCtD
Tretinoin—Syncope—Thalidomide—leprosy	0.00025	0.00183	CcSEcCtD
Tretinoin—Palpitations—Thalidomide—leprosy	0.000246	0.0018	CcSEcCtD
Tretinoin—Loss of consciousness—Thalidomide—leprosy	0.000245	0.00179	CcSEcCtD
Tretinoin—Cough—Thalidomide—leprosy	0.000243	0.00178	CcSEcCtD
Tretinoin—CYP1A1—nervous system—leprosy	0.000243	0.00464	CbGeAlD
Tretinoin—Convulsion—Thalidomide—leprosy	0.000241	0.00177	CcSEcCtD
Tretinoin—Hypertension—Thalidomide—leprosy	0.00024	0.00176	CcSEcCtD
Tretinoin—CYP2B6—testis—leprosy	0.00024	0.00459	CbGeAlD
Tretinoin—Arthralgia—Thalidomide—leprosy	0.000237	0.00174	CcSEcCtD
Tretinoin—Myalgia—Thalidomide—leprosy	0.000237	0.00174	CcSEcCtD
Tretinoin—Chest pain—Thalidomide—leprosy	0.000237	0.00174	CcSEcCtD
Tretinoin—Anxiety—Thalidomide—leprosy	0.000236	0.00173	CcSEcCtD
Tretinoin—CYP2B6—nervous system—leprosy	0.000236	0.00451	CbGeAlD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000235	0.00173	CcSEcCtD
Tretinoin—Discomfort—Thalidomide—leprosy	0.000234	0.00172	CcSEcCtD
Tretinoin—Dry mouth—Thalidomide—leprosy	0.000232	0.0017	CcSEcCtD
Tretinoin—Confusional state—Thalidomide—leprosy	0.000229	0.00168	CcSEcCtD
Tretinoin—Oedema—Thalidomide—leprosy	0.000227	0.00167	CcSEcCtD
Tretinoin—Infection—Thalidomide—leprosy	0.000226	0.00165	CcSEcCtD
Tretinoin—Shock—Thalidomide—leprosy	0.000224	0.00164	CcSEcCtD
Tretinoin—Nervous system disorder—Thalidomide—leprosy	0.000223	0.00163	CcSEcCtD
Tretinoin—Thrombocytopenia—Thalidomide—leprosy	0.000222	0.00163	CcSEcCtD
Tretinoin—Tachycardia—Thalidomide—leprosy	0.000222	0.00163	CcSEcCtD
Tretinoin—Skin disorder—Thalidomide—leprosy	0.000221	0.00162	CcSEcCtD
Tretinoin—Hyperhidrosis—Thalidomide—leprosy	0.00022	0.00161	CcSEcCtD
Tretinoin—Anorexia—Thalidomide—leprosy	0.000217	0.00159	CcSEcCtD
Tretinoin—Hypotension—Thalidomide—leprosy	0.000212	0.00156	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000207	0.00152	CcSEcCtD
Tretinoin—Insomnia—Thalidomide—leprosy	0.000206	0.00151	CcSEcCtD
Tretinoin—Paraesthesia—Thalidomide—leprosy	0.000204	0.0015	CcSEcCtD
Tretinoin—Dyspnoea—Thalidomide—leprosy	0.000203	0.00149	CcSEcCtD
Tretinoin—Somnolence—Thalidomide—leprosy	0.000202	0.00148	CcSEcCtD
Tretinoin—Dyspepsia—Thalidomide—leprosy	0.0002	0.00147	CcSEcCtD
Tretinoin—Decreased appetite—Thalidomide—leprosy	0.000198	0.00145	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Thalidomide—leprosy	0.000196	0.00144	CcSEcCtD
Tretinoin—Fatigue—Thalidomide—leprosy	0.000196	0.00144	CcSEcCtD
Tretinoin—Constipation—Thalidomide—leprosy	0.000194	0.00142	CcSEcCtD
Tretinoin—Pain—Thalidomide—leprosy	0.000194	0.00142	CcSEcCtD
Tretinoin—Feeling abnormal—Thalidomide—leprosy	0.000187	0.00137	CcSEcCtD
Tretinoin—Gastrointestinal pain—Thalidomide—leprosy	0.000186	0.00136	CcSEcCtD
Tretinoin—Urticaria—Thalidomide—leprosy	0.000181	0.00132	CcSEcCtD
Tretinoin—Abdominal pain—Thalidomide—leprosy	0.00018	0.00132	CcSEcCtD
Tretinoin—Body temperature increased—Thalidomide—leprosy	0.00018	0.00132	CcSEcCtD
Tretinoin—CYP3A4—nervous system—leprosy	0.000178	0.00341	CbGeAlD
Tretinoin—Hypersensitivity—Thalidomide—leprosy	0.000167	0.00123	CcSEcCtD
Tretinoin—Asthenia—Thalidomide—leprosy	0.000163	0.0012	CcSEcCtD
Tretinoin—Pruritus—Thalidomide—leprosy	0.000161	0.00118	CcSEcCtD
Tretinoin—Diarrhoea—Thalidomide—leprosy	0.000155	0.00114	CcSEcCtD
Tretinoin—Dizziness—Thalidomide—leprosy	0.00015	0.0011	CcSEcCtD
Tretinoin—Vomiting—Thalidomide—leprosy	0.000144	0.00106	CcSEcCtD
Tretinoin—Rash—Thalidomide—leprosy	0.000143	0.00105	CcSEcCtD
Tretinoin—Dermatitis—Thalidomide—leprosy	0.000143	0.00105	CcSEcCtD
Tretinoin—Headache—Thalidomide—leprosy	0.000142	0.00104	CcSEcCtD
Tretinoin—Nausea—Thalidomide—leprosy	0.000135	0.000989	CcSEcCtD
